This metabolite features a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 roughly 50% with the mother or father drug. Plasma concentrations of this metabolite are approximately forty% of those seen for sildenafil, so the metabolite accounts for about 20% of sildenafil's pharmacologic results.Fees of prescription p